<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04275661</url>
  </required_header>
  <id_info>
    <org_study_id>ESPB in breast cancer surgery</org_study_id>
    <nct_id>NCT04275661</nct_id>
  </id_info>
  <brief_title>Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery</brief_title>
  <official_title>Efficacy and Safety of Ketamine Versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound (US) Bi-level Erector Spinae Block in Breast Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim will be to compare the analgesic efficacy and safety of ketamine and magnesium
      sulphate as adjuvants to levobupivacaine in erector spinae plane block in modified radical
      mastectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participating females will be randomly allocated using computer generated randomizer
      program (http://www.randomizer.org) into one of 3 groups.

      Group (C) / (I): 20 patients (control group):

      Patient will receive 20 ml 0.25% levobupivacaine into interfascial plane below erector spinae
      muscle at level of T5 and T7.

      Group (K) / (II): 20 patients (Ketamine group):

      Patient will receive 20ml 0.25% levobupivacaine as above + 2 mg /kg ketamine.

      Group (M) / (III): 20 patients (magnesium sulphate group):

      Patient will receive 20ml 0.25% levobupivacaine as above + 2mg/kg MgSo4.

      Study protocol:

      Premedication will be given, after complete fasting hours after applying standard monitors
      (noninvasive blood pressure, pulse oximetery. ECG, temp, and capnography), an intravenous
      cannula will be placed and secured in the opposite side to surgery.

      Ultrasound guided Erector spinae plane (ESP) block will be given with patient in sitting
      position depending on surgical site (lt. or Rt.) ESP block will be given using high frequency
      linear u/s transducer, the probe is placed in longitudinal orientation lateral to thoracic
      fifth and seventh spinous process, then Trapezious m., Rhomboideus major muscle, and erector
      spinae muscle, are identified from surface, we will deposite 20 ml of 0.25% levobupivacairen
      into interfacial plane below erector spinae muscle.

      General anesthesia will be induced with lμg/kg fentanyl, 2mg/kg propofol, 0.5 mg/kg
      atracurium inhalational anesthesia (isoflurane or sevoflurane)

      1gm paracetamol after induction No other narcotic, analgesic or sedative will be
      administrated during operative period.

      Standard monitor (MABP, HR , SaO2 &amp; EtCo2) will be observed and recorded every 30 min till
      end of surgery Post-operative ; the patient will be transferred to the post anesthesia care
      unit (PACU). In PACU the following data included heart rate, mean blood pressure, respiratory
      rate and oxygen saturation and VAS scores (at rest and after movement in the form of
      abduction of ipsilateral arm ) at baseline,2,4,6,12,24 and 48 hours post-operatively to
      evaluate acute pain will be observed and recorded. The attending anesthesiologist, surgeon
      and the data collecting personal will be unaware of the patient assignment.

      Rescue post-operative analgesia in the form of morphine Patient controlled analgesia (PCA )
      with an initial bolus of 0.1 mg/ kg morphine once pain is expressed followed by 1mg bolus
      with a locked period of 15 minutes with no back ground infusion allowed. The time to first
      request of analgesia and the total analgesic consumption in the 1st 48 hour will be observed
      and recorded. Postoperative adverse effects will be observed and treated
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total morphine consumption in first 48 hours</measure>
    <time_frame>48 hours</time_frame>
    <description>determine the analgesic effect of ketamine and magnesium sulphate in decreasing morphine consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time to first request of analgesia</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Analgesia</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Group (C) (control group)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient will receive 10 ml 0.25% levobupivacaine into interfascial plane below erector spinae muscle at level of T5 and 10 ml at level of T7.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (K) (Ketamine group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive 10 ml 0.25% levobupivacaine into interfascial plane below erector spinae muscle at level of T5 and 10 ml at level of T7+ 1 mg / kg ketamine at each level with total dose 2mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (M) (magnesium sulphate group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive 10 ml 0.25% levobupivacaine into interfascial plane below erector spinae muscle at level of T5 and 10 ml at level of T7+ 1 mg / kg MgSo4 at each level with total dose 2mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound (US) bi-level erector spinae block</intervention_name>
    <description>nerve block</description>
    <arm_group_label>Group (C) (control group)</arm_group_label>
    <arm_group_label>Group (K) (Ketamine group)</arm_group_label>
    <arm_group_label>Group (M) (magnesium sulphate group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>20 ml 0.25% levobupivacaine injected into fascial plane deep to erector spinae muscle</description>
    <arm_group_label>Group (C) (control group)</arm_group_label>
    <arm_group_label>Group (K) (Ketamine group)</arm_group_label>
    <arm_group_label>Group (M) (magnesium sulphate group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>2 mg /kg ketamine.injected into fascial plane deep to erector spinae muscle</description>
    <arm_group_label>Group (K) (Ketamine group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>2mg/kg Magnesium Sulfate .injected into fascial plane deep to erector spinae muscle</description>
    <arm_group_label>Group (M) (magnesium sulphate group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18 - 60 years.

          -  ASA grade I - II.

        Exclusion Criteria:

          -  Patient refusal. known allergy to the study drugs skin infection at site of needle
             puncture significant organ dysfunction Coagulopathy drug or alcohol abuse psychiatric
             illness that would interfere with perception and assessment of pain.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>khaled fares</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>hamdy abbas</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>fatma adel</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ali rabiee</last_name>
    <phone>00201097864636</phone>
    <email>alirabieeali@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>south Egypt Cancer Institute Assiut University</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ali rabiee, resident</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Altıparmak B, Korkmaz Toker M, Uysal Aİ, Gümüş Demirbilek S. Bi-level erector spinae plane block for the control of severe back pain related to vertebral metastasis. BMJ Case Rep. 2019 Jun 20;12(6). pii: e228129. doi: 10.1136/bcr-2018-228129.</citation>
    <PMID>31227568</PMID>
  </reference>
  <reference>
    <citation>Kwon WJ, Bang SU, Sun WY. Erector Spinae Plane Block for Effective Analgesia after Total Mastectomy with Sentinel or Axillary Lymph Node Dissection: a Report of Three Cases. J Korean Med Sci. 2018 Nov 5;33(45):e291. doi: 10.3346/jkms.2018.33.e291.</citation>
    <PMID>31044575</PMID>
  </reference>
  <reference>
    <citation>Gürkan Y, Aksu C, Kuş A, Yörükoğlu UH, Kılıç CT. Ultrasound guided erector spinae plane block reduces postoperative opioid consumption following breast surgery: A randomized controlled study. J Clin Anesth. 2018 Nov;50:65-68. doi: 10.1016/j.jclinane.2018.06.033. Epub 2018 Jul 2.</citation>
    <PMID>29980005</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 14, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ali Rabiee Ali</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

